K Pharma,Inc. Company Description

K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan.

It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions.

The company was incorporated in 2016 and is based in Minato, Japan.

K Pharma,Inc.

Country	Japan
Founded	2016
Industry	Biotechnology
Sector	Healthcare
CEO	Hiroaki Fukushima

Contact Details

Address: Tri-Seven Roppongi Minato, 106-0032 Japan
Website	kpharma.co.jp

Stock Details

Ticker Symbol	4896
Exchange	Tokyo Stock Exchange
Reporting Currency	JPY
ISIN Number	JP3280900006
SIC Code	2836

Key Executives

Name	Position
Hiroaki Fukushima	Chief Executive Officer
Masato Matsumoto	Chief Financial Officer